Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Microbiologics Acquires Phthisis Diagnostics, New Direction Exhibited at Current Meeting of the Association for Molecular Pathology

By LabMedica International staff writers
Posted on 11 Nov 2013
Phthisis Diagnostics (Charlottesville, VA, USA) has announced its acquisition by Microbiologics (St. More...
Cloud, MN, USA) to establish Phthisis’ technology as the foundation for a new division at Microbiologics.

Pthisis’ patented “G-Sphere” molecular standards product line will be the foundation for Microbiologics’ launch into molecular products and for the new division it is forming. G-Sphere standards are synthetic genes that provide easy-to-use, safe, stable, consistent, and abundant controls for virtually any organism or molecular assay. Currently, Microbiologics produces an array of lyophilized microorganism products in convenient, ready-to-use formats for quality control of microbiological testing.

Crystal Icenhour, PhD, adjunct assistant professor of infectious diseases at Duke University Medical Center, and President and Chief Science Officer at Phthisis since 2006, along with her research team, created the new technology. She will serve as an advisor with Microbiologics during the adoption of Phthisis’ technology and development of their new division. “We introduced this product line about a year ago to provide much needed quality control standards to molecular laboratories. I am pleased that this longer established company will have the structure to take these products much further than our smaller company could have,” said Prof. Icenhour.

Brad Goskowicz, Microbiologics CEO, commented, “These innovative molecular standards will lay the foundation for Microbiologics to design and launch a broad collection of molecular products and custom services. It will expand our range of biomaterials to include viruses and other hard to grow microorganisms.”

Microbiologics is adding Brian Beck, PhD in bacteriology, to its senior management team as Vice President of Molecular Products and Services. Dr. Beck has spent the last ten years at ATCC in Virginia where he managed the Microbiology Collection and Associated BioServices. “I’m quite excited to extend what Microbiologics has done with their culture business and bring that same practical, user-friendly format to the molecular diagnostic business,” said Dr. Beck.

To commence their new initiative, Microbiologics is exhibiting at the Association for Molecular Pathology (AMP) annual meeting, November 14-16, 2013, Phoenix (Arizona, USA).

Related Links:

Phthisis Diagnostics
Microbiologics



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.